Top 50 Biotechnology Startup Investors in Austria (May 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
xista science ventures
VC Fund
|
8 | Austria | Seed, Pre-Seed, Series A | Biotechnology, Medical, Software | |
|
tecnet equity
VC Fund
|
6 | Austria | Seed, Series A | Software, SaaS, Information Technology | $214k–$5.9M |
|
MIG Capital
VC Fund
|
5 | Germany, Austria, Canada | Series A, Series B | Biotechnology, Health Care, Pharmaceutical | $1.6M–$26M |
|
aws Fondsmanagement GmbH
VC Fund
|
5 | Austria, Belgium | Seed, Grant, Pre-Seed | Software, Information Technology, Health Care | $43k–$2.1M |
|
Schnidar Harald
Angel
|
3 | Austria | Seed, Angel, Pre-Seed | mHealth, Software, Biopharma | |
|
Arax Capital Partners
VC Fund
|
3 | Austria | Seed | Biotechnology, Health Care, Medical | |
|
aws Gründerfonds (aws Founders Fund)
VC Fund
|
2 | Austria, United States, Germany | Seed, Series A | Software, SaaS, Information Technology | $536k–$8.6M |
|
Longevitytech.fund
VC Fund
|
2 | United States, United Kingdom, The Netherlands | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Personal Health | $255k–$3.2M |
|
APEX Ventures
VC Fund
|
2 | Germany, Austria, United Kingdom | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Information Technology | $643k–$16M |
|
PUSH Ventures
VC Fund
|
2 | Austria, Germany, United States | Seed, Series A | Software, Apps, Health Care | $450k–$7.4M |
|
TSVC
VC Fund
|
2 | United States, China, Canada | Seed, Series A | Software, Artificial Intelligence, Health Care | $500k–$14M |
|
Aescap Venture
VC Fund
|
2 | United Kingdom, Austria, Belgium | Series A, Series B | Biotechnology, Pharmaceutical, Chemical | $4.9M–$24M |
|
bmp Ventures
VC Fund
|
2 | Germany, United States, Austria | Seed, Series A | Information Technology, Software, Manufacturing | $29k–$4.3M |
|
Nina Capital
VC Fund
|
2 | United States, United Kingdom, Austria | Seed, Pre-Seed, Series A | Health Care, Artificial Intelligence, Medical | $573k–$21M |
|
R42 Group
VC Fund
|
2 | United Kingdom, United States, Austria | Seed, Pre-Seed, Series A | Biotechnology, Health Care, Information Technology | $429k–$15M |
|
red-stars.com
VC Fund
|
2 | Austria, Germany | Seed | Software, Biotechnology, Telecommunications | $1.6M–$4.3M |
|
10x Founders
VC Fund
|
1 | Germany, United States, India | Seed, Series A, Pre-Seed | Software, Information Technology, Human Resources | $2.7M–$23M |
|
Climentum Capital
VC Fund
|
1 | Sweden, Spain, Austria | Seed, Series A, Series B | CleanTech, Clean Energy, Biotechnology | $5M–$6.4M |
|
EIT Health
VC Fund
|
1 | United Kingdom, Spain, Ireland | Grant, Pre-Seed, Seed | Health Care, Medical Device, Medical | $21k–$1.4M |
|
Amino Collective
VC Fund
|
1 | Germany, United States, United Kingdom | Seed, Series A, Pre-Seed | Health Care, Biotechnology, Software | $2.9M–$6M |
|
Andera Partners
VC Fund
|
1 | France, United States, Germany | Series B, Private Equity | Biotechnology, Health Care, Medical | $11M–$241M |
|
Matthias Wilrich
Angel
|
1 | Germany, Austria, Malaysia | Seed, Pre-Seed, Series A | E-Commerce, Delivery Service, Mobile Apps | $1.3M–$14M |
|
BackBone Ventures
VC Fund
|
1 | Switzerland, Germany, Israel | Seed, Convertible Note, Series A | Information Technology, Financial Services, Robotics | $600k–$11M |
|
MCI Capital SA
VC Fund
|
1 | Poland, Germany, United Kingdom | Series A, Seed | E-Commerce, Software, Mobile | $589k–$8.8M |
|
Übermorgen Ventures
VC Fund
|
1 | Germany, Switzerland, Finland | Seed, Pre-Seed | Energy, Software, Renewable Energy | $328k–$4.3M |
|
ICL Planet Startup Hub
VC Fund
|
1 | Israel, Austria | Seed | Biotechnology, Agriculture, Organic Food | $4.3M–$10M |
|
Forbion Capital Partners
VC Fund
|
1 | United States, United Kingdom, The Netherlands | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $4.5M–$115M |
|
Sofinnova Partners
VC Fund
|
1 | France, United States, United Kingdom | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $4.4M–$57M |
|
HBM Partners
VC Fund
|
1 | United States, Germany, Switzerland | Series B, Series C | Biotechnology, Medical, Health Care | $2.5M–$125M |
|
The Austrian Research Promotion Agency (FFG)
VC Fund
|
1 | Austria, United States, Belgium | Grant, Seed, Angel | Software, Health Care, Information Technology | $66k–$3.5M |
|
Kale United
VC Fund
|
1 | United Kingdom, Sweden, India | Seed, Pre-Seed | Food and Beverage, Food Processing, Biotechnology | $100k–$1.4M |
|
HackCapital
VC Fund
|
1 | United States, Israel, United Kingdom | Seed, Pre-Seed, Series A | Food and Beverage, Biotechnology, Food Processing | $500k–$12M |
|
Tet Ventures
VC Fund
|
1 | United States, Germany, United Kingdom | Seed, Pre-Seed, Series A | Food and Beverage, Biotechnology, E-Commerce | $150k–$6M |
|
Satgana
VC Fund
|
1 | Germany, United States, The Netherlands | Pre-Seed | Energy, Software, CleanTech | $600k–$1.4M |
|
Wellcome Trust
VC Fund
|
1 | United States, United Kingdom, Germany | Grant, Series C | Biotechnology, Health Care, Pharmaceutical | $1.2M–$90M |
|
OrbiMed
VC Fund
|
1 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | $10M–$120M |
|
IPO Beteiligungs-Management
VC Fund
|
1 | Austria | Series B | Sensor, Medical, Wireless | |
|
IBG Beteiligungsgesellschaft Sachsen-Anhalt
VC Fund
|
1 | Germany, Austria | Seed, Series A | Electronics, Software, Medical Device | |
|
FastVentures
VC Fund
|
1 | Hungary, South Korea, United States | Seed, Series A, Series B | Software, Biotechnology, Information Technology | |
|
FCPG Affi
VC Fund
|
1 | Austria | Medical, Biotechnology, Pharmaceutical | ||
|
Polaris Partners
VC Fund
|
1 | United States, Singapore, Ireland | Series B, Series A, Series C | Biotechnology, Health Care, Medical | $3.5M–$117M |
|
HCVC
VC Fund
|
1 | United States, France, United Kingdom | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, Manufacturing | $250k–$31M |
|
Die Wirtschaftskammer
VC Fund
|
1 | Austria | Seed, Pre-Seed | Software, Music, mHealth | |
|
Axilium Holding
VC Fund
|
1 | Austria | Seed | Life Science, Biotechnology, Semiconductor | |
|
4SC
VC Fund
|
1 | Austria | Seed | Health Care, Biotechnology | |
|
Pace Ventures Enigma
VC Fund
|
1 | Germany, United States | Seed | Drones, Medical, Software | |
|
Lansdowne Investment Company Cyprus
VC Fund
|
1 | Austria | Seed | Life Science, Biotechnology, Semiconductor | |
|
RKP InnoInvest
VC Fund
|
1 | Austria | Seed | Food and Beverage | |
|
Gamma Capital Partners
VC Fund
|
1 | Austria, Switzerland, United States | Series A, Seed, Series C | Mobile, iOS, Mobile Apps | $546k–$621k |
|
GLS Ventures
VC Fund
|
1 | Austria | Series B | Medical, Health Care, Biotechnology | |
| Access all 101 investors in Austria Biotechnology startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.
Show more...Investment focus
- Industry: Biotechnology, Medical, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: Austria
Investor stats
- Total investments: 19
- Lead/follow: 70% lead, 30% follow
Portfolio highlights
- Prewave — Supplier monitoring for purchasing, supply chain management and sustainability managers.
- subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
- ReCatalyst — REvolutionizing the way we make fuel cell CATALYSTs
tecnet equity is an Austrian venture capital fund investing in innovative high-tech companies with potential for significant growth.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: Austria
Investor stats
- Total investments: 52
- Round size: Seed $214k–$964k; Series A $570k–$5.9M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — last raise in 2009
Portfolio highlights
- Circly — Determining tomorrow's needs through sales figures is one of Circly's core competencies, but we go one step further:Circly develops interactive AI construction modules for retailers. Thanks to our modular concept, our users can choose the influencing factors themselves and weight them differently, so that the AI can be adapted to thecompany at any time.With Circly, the supply chain and warehouse utilization can be brought to the next level. We are about to pilot the system and are looking for retailers who are interested in case studies.Description: Machine Learning based Prediction System for the retail sector to forecast the demand in order to avoid food waste, out of stocks and overstock. Other benefits include insights into customer segments and groups, product trends, the possibility of dynamic pricing and marketing!
- Sarcura — Sarcura develops a machine platform for the large scale, GMP manufacturing of personalized cell therapies. Our target is to scale global manufacturing capacity for these life saving, patient specific cancer treatments, cost effective and safe for a all patients. We will transform existing manufacturing paradigms by using semiconductor technologyto bring bioprocess control to cellular level.
- Shopstory — boomerank is a SaaS that helps eCommerce companies grow automatically with help of a powerful AI and the creation of an immense data hub.
Zusammen gestalten wir die Unternehmen von morgen.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series A, Series B
- Geography: Germany, Austria, Canada
Investor stats
- Total investments: 80
- Round size: Series A $1.8M–$9M; Series B $1.6M–$26M
- Lead/follow: 46% lead, 54% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- AMSilk — AMSilk produces and distributes high-quality silk biopolymers for use in textile products, medical devices, and cosmetics.
- mbiomics — mbiomics is a biotechnology company.
- Look Up Space — Lookup space is the next global leader for space safety, security and sustainability
The Austrian Economic Service mbH (aws) is the promotional bank of the Federal Government.The aws SME fund is the largest Austrian Fund for silent corporate investments, but also providers of equity. Founded in late 2009 by the Austrian Economic Service mbH (aws) - the Development Bank of the Federal - he has a term until 31/12/2025.The fund is currently endowed with EUR 80 million and participates in medium-sized companies and brings with it a fresh capital to develop new products or processes, for sales development to international expansion.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Grant, Pre-Seed
- Geography: Austria, Belgium
Investor stats
- Total investments: 38
- Round size: Seed $214k–$2.1M; Grant $107k–$589k; Pre-Seed $43k–$338k
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Brusli — Brusli provides solutions and strategies for the reduction of food waste.
- revitalyze — revitalyze is an award-winning greentech platform that enables a circular construction industry through a unique approach to the reuse of building elements.
- Lightning Company — The Lightning Company is the first EU-based bitcoin and lightning payment gateway. We want to make bitcoin payments as easy and attractive as possible, ensuring that customers have no additional costs, whilst merchants receive attractive processing fees.
Entrepreneur, Angel Investor, Scientist and Inventor
Show more...Investment focus
- Industry: mHealth, Software, Biopharma
- Stage:Seed, Angel, Pre-Seed
- Geography: Austria
Investor stats
- Total investments: 7
- Lead/follow: 86% lead, 14% follow
Portfolio highlights
- SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
ARAX Capital Partners is an Austrian bio-tech and high-tech early stage investor with an exclusive focus on Austrian ventures. Companies need to be young, innovative (if possible with patentable technology) and must have already secured pre-seed funding to qualify for an investment
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed
- Geography: Austria
Investor stats
- Total investments: 4
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
- Panoptes Pharma — Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria.The development of Panoptes´ clinical candidate PP-001 focuses on a new treatment for autoimmune uveitis, a disease whichis one of the major causes of blindness. As a second indication, adenoviral conjunctivitis will be pursued, a disease for which to date, no treatment is available. Due to its unique mode of action, PP-001 has therapeutic potential for additional inflammatory and viral indications.Panoptes has an experienced team of development experts with a proven track record of developing and commercializing innovative products. The team is developing a focused portfolio of high-performance small molecule products, with its lead clinical candidate PP-001 in preclinical development.
- Calyxha Biotechnologies GmbH — A new perspective on inflammation
aws Gründerfonds is Austria's 70m venture capital fund. We invest as co-investor in Austrian high-growth start-ups in their later seed and (pre-)series-A stages.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Seed, Series A
- Geography: Austria, United States, Germany
Investor stats
- Total investments: 73
- Round size: Seed $536k–$3.2M; Series A $696k–$8.6M
- Lead/follow: 7% lead, 93% follow
Portfolio highlights
- Valutico — Valutico is the world‘s leading provider of web-based company valuation tools.Started in 2014 by a team of enthusiastic Corporate Finance professionals and web developers, the concept was born out of frustration with the status-quo in Corporate Finance practice: That professional company valuations used to be the domain of only the mostsophisticated of investors.At Valutico, it has been their mission from the outset to offer cutting-edge valuation tools to a much wider audience. Today they empower everybody to perform company valuations that meet and exceed the standards of even the leading investment banks and advisory firms.The company today is headquartered in Vienna/Austria and has an additional office in Frankfurt/Germany.
- ToolSense — Connecting the way OEMs do business.ToolSense enables OEMs to improve customer service, generate insights for R&D and increase customer loyalty - through digitizing their products with the 'ToolSense NOW' IIoT platform and 'ToolSense IOT' Hardware.ToolSense is the winner of Austrian Foreign Trade Award "Born GlobalChampion 2018", ORF Futurezone Award "Best IoT Startup 2017", part of Deutsche Telekom's "hub:raum NB-IoT Warp Program", part of SAP's "Startup Focus Program" and part of University of Applied Sciences Technikum Vienna's "Student Startup Incubator Program".
- Arkeon Biotechnologies — Arkeon turns CO2 into functional, carbon-negative ingredients for food
Investing globally in technologies extending healthy lifespans
Show more...Investment focus
- Industry: Biotechnology, Health Care, Personal Health
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 45
- Round size: Seed $255k–$3.2M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- SiPhox Health — SiPhox offers a handheld testing device with RNA/DNA and protein testing for point-of-care and At-Home solutions. The company's kit is made by multiplexing RNA, antibody, and antigen tests on a single silicon photonic chip which is amplified by plasmon resonance and silicon photonic resonator readout, enabling users to undertake tests fordisease safely and in a disposable point-of-care and at-home manner.SiPhox was founded in 2020 and is based in Cambridge, Massachusetts, USA.
- Cosmica Biosciences — Cosmica.bio - Rewiring molecular resilience for longevity & space exploration
- Rejuvenation Technologies — Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres. The company is headquartered in Mountain View, California.
APX Ventures offers digital solutions, including pay-per-click, custom web services, SEO, and cloud services.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, Austria, United Kingdom
Investor stats
- Total investments: 40
- Round size: Seed $643k–$5.9M; Pre-Seed $643k–$1.7M; Series A $6M–$16M
- Lead/follow: 28% lead, 72% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- sewts — Founded in 2019 and based in Munich, sewts GmbH provides cutting-edge perception software, pushing the boundaries of robotics in processing of easily deformable materials. sewts has developed and demonstrated a unique technology that uses high-precision finite element method (FEM) simulations to efficiently train machine learning algorithms. Theintelligent software solution enables countless applications in industrial automation like the handling of textiles in industrial laundries or the manufacturing of garment. sewts is backed by APEX Ventures, Bayern Kapital, High-Tech Gründerfonds, UnternehmerTUM Initiative for Industrial Innovators and a couple of highly experienced business angels.
- Zetta Genomics — Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world - and realise the potential of
- Refined Laser Systems — Refined Laser Systems is a dynamic biophotonics company.It specialises in creating innovative laser systems for SRS-microscopy and quantum technology.
We are an early-stage Venture Capital Firm investing in outstanding teams with convincing products and high growth potential.
Show more...Investment focus
- Industry: Software, Apps, Health Care
- Stage:Seed, Series A
- Geography: Austria, Germany, United States
Investor stats
- Total investments: 26
- Round size: Seed $450k–$6M; Series A $5M–$7.4M
- Lead/follow: 12% lead, 88% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- FERNRIDE — Fernride enables automated, sustainable logistics by combining the skills of remote drivers with autonomous technologies.
- Valutico — Valutico is the world‘s leading provider of web-based company valuation tools.Started in 2014 by a team of enthusiastic Corporate Finance professionals and web developers, the concept was born out of frustration with the status-quo in Corporate Finance practice: That professional company valuations used to be the domain of only the mostsophisticated of investors.At Valutico, it has been their mission from the outset to offer cutting-edge valuation tools to a much wider audience. Today they empower everybody to perform company valuations that meet and exceed the standards of even the leading investment banks and advisory firms.The company today is headquartered in Vienna/Austria and has an additional office in Frankfurt/Germany.
- Ohana — Ohana helps you to protect your child in the digital world. Limit screentime, get insights & guidance, block apps & websites and filter inappropriate content.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A
- Geography: United States, China, Canada
Investor stats
- Total investments: 191
- Round size: Seed $500k–$3M; Series A $2M–$14M
- Lead/follow: 7% lead, 93% follow
- Last fund: May invest from a new fund soon — last raise in 2020
Portfolio highlights
- Angle Health — Digital-First Health Plans For The Modern Employee
- KURUKURU — Bring your comics and visual stories to life in clicks on KURUKURU.
- Leadoptik — Leadoptik is a California-based company is currently operating in stealth mode.
The Aescap funds invest in highly innovative publicly traded biotech/life sciences companies. We're able to select the promising companies
Show more...Investment focus
- Industry: Biotechnology, Pharmaceutical, Chemical
- Stage:Series A, Series B
- Geography: United Kingdom, Austria, Belgium
Investor stats
- Total investments: 13
- Round size: Series B $4.9M–$24M
- Lead/follow: 31% lead, 69% follow
Portfolio highlights
- Orphazyme — Orphazyme develops innovative new therapies for the treatment of a family of serious genetic disordes called lysosomal storage diseases, and is based on discoveries emerging from the academic laboratory of its scientific founders: Professor Marja Jäättela and Thomas Kirkegaard Jensen from the Danish Cancer Society (Kræftens Bekæmpelse).Orphazyme is based in Copenhagen and has established collaborations with top-tier academic institutions in Europe and USA.
- Avantium — Avantium is a leading technology company specialized in advanced high-throughput R&D for applications in the energy, chemicals and pharmaceutical industries. The company's headquarters and laboratories are located in Amsterdam, in the Netherlands.Avantium's proprietary high-throughput technology enables a faster and morecost-effective development of new and improved products and production processes. Using its unique rational approach towards the design of experiments and data analysis, Avantium is capable of accomplishing innovations with superior success rate. Avantium has demonstrated the validity and commercial viability of its technology by successfully providing research services and tools to more than 70 companies worldwide, including many industry leaders. The company's mission is to increase the success rate and economics of product and process development.Building on its expertise and track record in the energy, chemicals and pharmaceutical industries, Avantium focuses on developing products in two fields:new biofuels and bio-based chemicals, and new crystal forms of marketed drugs under patent.Avantium's strategy is to progress its development programs and exploit the commercial value of its expanding patent portfolio by securing value-adding partnerships during the coming years. Avantium seeks continuous expansion of its profitable services and tools business.Avantium has assembled a team of highly educated professionals who are experts in catalysis, crystallography, organic chemistry, engineering of robotic systems, process engineering, statistics, cheminformatics and software development. Its teams collaborate closely with partner R&D organizations.
- F-Star Therapeutics — F-star is a clinical stage biotech developing next generation immunotherapies to transform the lives of patients with cancer. We are developing transformational cancer immunotherapies for patients who have few remaining options.
bmp Ventures is an innovative Venture Capital Company from Berlin. Since 1997 we’ve been investing Smart Money in Early Stage and Growth Startups. We finance ingenious business models with outstanding teams, who build fast-growing and sustainably profitable enterprises.
Show more...Investment focus
- Industry: Information Technology, Software, Manufacturing
- Stage:Seed, Series A
- Geography: Germany, United States, Austria
Investor stats
- Total investments: 102
- Round size: Seed $148k–$2.4M; Series A $29k–$4.3M
- Lead/follow: 38% lead, 62% follow
- Last fund: Likely still investing — raised $2.5M in 2022
Portfolio highlights
- Neotiv — Enabling cognitive health
- Wingfield — Wingfield ist dein Zugang zu einem virtuellen Tenniserlebnis.
- InLine-Med — Radiologists perform safe, precise & easy interventions with the InLine-Med surgical tools and assistance devices.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Medical
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, United Kingdom, Austria
Investor stats
- Total investments: 58
- Round size: Seed $1.2M–$6M; Pre-Seed $573k–$964k; Series A $5M–$21M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- basys.ai — Basys.ai automates the process of prior authorization and utilization management to improve costs and timeliness for health plans/payers using an AI-based platform. The proprietary platform automates the process of encoding/digitizing the payer policies using machine learning, thus reducing the piloting timeline by up to 9 months.
- Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
- ALFIE — AI software platform that provides consistent and automated measurements from radiographic images used to assess spinal disorders.
R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Information Technology
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Austria
Investor stats
- Total investments: 23
- Round size: Seed $614k–$4M; Pre-Seed $429k–$2M; Series A $4.2M–$15M
- Lead/follow: 26% lead, 74% follow
Portfolio highlights
- Silveray — Silveray develop affordable large-area direct conversion detectors for the X-ray imaging market.
- KetoSwiss — KetoSwiss is a Swiss-based BioTech startup that strives to bring ketone bodies back into the modern world to combat diseases. It develops and clinically tests a novel nutraceutical/medical food for the dietary preventive therapy of higher-frequency migraines and possibly other related neurological diseases characterized by a metabolicdysfunction (such as Alzheimer's disease). KetoSwiss is headquartered at the Technologie Park Basel, in Basel Switzerland, where it is part of a dynamic scientific and entrepreneurial community composed of world-leading academic research laboratories, flourishing life sciences spin-offs and s world-leading biotech-startup-ecosystem.
- WiseWorks — AI-Powered Communications Intelligence for Financial Institutions
red-stars.com is an operative holding company that invests in and manages companies that provide mission-critical products and offerings to enable DIGITALIZATION and LIFE SCIENCES.
Show more...Investment focus
- Industry: Software, Biotechnology, Telecommunications
- Stage:Seed
- Geography: Austria, Germany
Investor stats
- Total investments: 7
- Round size: Seed $1.6M–$4.3M
- Lead/follow: 86% lead, 14% follow
Portfolio highlights
- Txture — Txture is an end-to-end cloud transformation platform for planning transformations, migration management and cloud infrastructure optimization.
- a:head bio — a:head aims to develop new therapeutics for the treatment of brain disorders based on human cerebral organoids
- HeartBeat.bio — HeartBeat.bio is a privately funded drug discovery company focusing on the development of a high-throughput 3D screening platform for heart failure and cardiomyopathies.
Cutting-edge venture capital firm supporting the early-stage entrepreneurs building global businesses.
Show more...Investment focus
- Industry: Software, Information Technology, Human Resources
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, India
Investor stats
- Total investments: 36
- Round size: Seed $2.7M–$12M; Series A $7.5M–$23M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- FERNRIDE — Fernride enables automated, sustainable logistics by combining the skills of remote drivers with autonomous technologies.
- LastMile AI — Prototype and productionize generative AI apps. Built for engineers, not just ML practitioners
- ThreatFabric — Our Fraud Risk Suite enables safe & frictionless payment journeys by combining our renowned threat intel with device/behavioral/identity risk management.
A Venture Capital firm investing into European early-stage tech companies attacking CO2 emissions
Show more...Investment focus
- Industry: CleanTech, Clean Energy, Biotechnology
- Stage:Seed, Series A, Series B
- Geography: Sweden, Spain, Austria
Investor stats
- Total investments: 9
- Round size: Series A $5M–$6.4M
- Lead/follow: 78% lead, 22% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Fermify — We are here to domesticate microorganisms and build simple and fully automated production platform to address the issue of large-scale milk protein production
- Jolt Electrodes — Jolt Solutions is an innovative catalytic coatings for industrial electrodes. Learn more about the key benefits of Green Hydrogen.
- Novatron — A new fusion reactor design for stable plasma confinement and fusion power generation.
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Grant, Pre-Seed, Seed
- Geography: United Kingdom, Spain, Ireland
Investor stats
- Total investments: 88
- Round size: Seed $536k–$1.4M; Grant $21k–$1.2M; Pre-Seed $43k–$1.4M
- Lead/follow: 59% lead, 41% follow
Portfolio highlights
- Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
- ZiO Health — ZiO Health develops multi-functional electronic devices for measuring, testing and detecting the molecular composition of chemical and biological substances for the presence, absence, or quantity of target molecules.
- Nanordica Medical — Nanordica Medical develops novel nanoparticle-based antibacterial wound care products.
Amino Collective is an investment firm. They enable entrepreneurs and scientists to establish businesses that generate a better future for all species on Earth. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, life science, and synthetic biology.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: Germany, United States, United Kingdom
Investor stats
- Total investments: 24
- Round size: Seed $2.9M–$6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Lindus Health — Lindus Health. From recruitment to delivery, we accelerate clinical trials. Our mission is to make health research accessible for everyone, everywhere.
- Enveda Biosciences — Enveda Biosciences is a biotechnology company building new medicines from plants. It harnesses the complexity of the natural world to tackle today’s biggest healthcare challenges. With the help of the advancements in knowledge graphs, machine learning, and metabolomics, they discover the next generation of small molecules. Its technologiessystematize the discovery of small molecules and novel targets for complex diseases. By probing novel chemical space and mechanisms of action, they are breaking the status quo for challenging diseases with a need for effective treatments, such as fibrosis or neurodegeneration.Enveda, launched in 2019, is based in San Francisco, California.
- Sensible Biotechnologies — Engineering cells to make better mRNA.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Andera Partners, formerly known as Edmond de Rothschild Investment Partners (EdRIP) As heir to the traditions and values that have ensured the success of the Rothschild family for 250 years, the Edmond de Rothschild Group has established itself over time as a leading player in European finance. Its activities are grouped around two major areas:Private Banking and Asset Management. The Group offers wealthy families, entrepreneurs, and large institutions a full range of solutions combining a culture of tailored solutions, stability, performance, and innovation. The Edmond de Rothschild Group’s offering is characterised by strong convictions, with the desire to guarantee to each of its customers: A unique, close relationship, underpinned by the know-how and the variety of expertise of a large international group; Autonomous, experienced teams, who anticipate economic trends and innovate to establish long-term performance; The recognised stability, strength, and independence of a family-owned financial group. Founded by Baron Edmond de Rothschild in 1953, the Group has been chaired by his son, Baron Benjamin de Rothschild, since 1997.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Private Equity
- Geography: France, United States, Germany
Investor stats
- Total investments: 146
- Round size: Series B $11M–$75M; Private Equity $107M–$241M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — fund raised in 2022
Portfolio highlights
- Evommune — Evommune is taking a tissue-based approach to advance insights and accelerate the development of transformative medicines in inflammatory diseases.
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
- Ariceum Therapeutics — Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.
Matthias Wilrich is the VP Vehicles and Supply Chain at TIER Mobility.
Show more...Investment focus
- Industry: E-Commerce, Delivery Service, Mobile Apps
- Stage:Seed, Pre-Seed, Series A
- Geography: Germany, Austria, Malaysia
Investor stats
- Total investments: 10
- Round size: Seed $1.3M–$14M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Lumaly — Lumaly is a browser extension that automatically tries out and uses all available voucher codes in the cart when shopping online.
- MAYD — MAYD provides telepharmacy platform providing healthcare-related goods in a convenient way by delivering it to doorstep.
- HELLO INSIDE — HELLO INSIDE is a scientific self care company empowering people to have data-driven conversations with their bodies. Unlock your best self.
BackBone Ventures' focus are early-stage investments, primarly in the area of innovative ICT, FoodTech and disruptive technologies in DACH & Israel. Committed to achieve a positive impact for the next generation by empowering access to proficient ventures investments.
Show more...Investment focus
- Industry: Information Technology, Financial Services, Robotics
- Stage:Seed, Convertible Note, Series A
- Geography: Switzerland, Germany, Israel
Investor stats
- Total investments: 35
- Round size: Seed $819k–$4M; Series A $5M–$11M; Convertible Note $600k–$8M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Aepsy — Finde Psychologinnen oder Psychologen, die zu dir und deinem Anliegen passen. Freite Termine und kostenlose Intros jederzeit online.
- Fermify — We are here to domesticate microorganisms and build simple and fully automated production platform to address the issue of large-scale milk protein production
- Exakt Health — Exakt Health is the physio app for sports injuries. The Exakt Health app guides users through self-diagnosis for frequent sports injuries and then creates an individualized rehabilitation plan.
MCI Capital is a leading Digital Private Equity investor in CEE, based in Warsaw, Poland. MCI Capital seeks to invest in digital disruption, transformation and infrastructure within EU, with focus on CEE. Preferred sectors are SaaS, E-commerce, Marketplace, Fintech, Insurtech, Foodtech, Traveltech and Digital Infrastructure. MCI typically investsEUR 25-100 M in a single project, either in Buyout or Expansion stage. Historically, MCI Capital has also been involved in funds dedicated to Private Debt, Growth and Venture Capital areas – these funds do not conduct any new investments, instead they focus on building the value of assets and de-investing.MCI Capital is managed by the executive management team. The company is listed on the Warsaw Stock Exchange since February 2001 and is also a member of the Polish Private Equity Association.
Show more...Investment focus
- Industry: E-Commerce, Software, Mobile
- Stage:Series A, Seed
- Geography: Poland, Germany, United Kingdom
Investor stats
- Total investments: 41
- Round size: Seed $1.1M–$1.5M; Series A $589k–$8.8M
- Lead/follow: 73% lead, 27% follow
Portfolio highlights
- IdoSell —
- Gett — Gett is a technology platform focused on corporate Ground Transportation Management (GTM), where spend is estimated to exceed $100 billion globally. https://gett.com/why We are the GTM category leader, serving over a quarter of the Fortune 500 companies.Gett’s cloud-based software organizes thousands of transportation providers(corporate fleet, ride-hailing, taxi, and limos) into one single platform. The technology helps save businesses time and money by managing all their ground transportation spend, and optimizes the entire employee experience from booking and riding to invoicing and analytics.We are building the first ground transportation grid available to customers worldwide, similar to telephony and internet grids, with aspirations to become the standard in corporate ground transportation, just as Zoom became the standard in corporate communication.Founded in 2010 and headquartered in London, Gett has raised more than $750M in funding to date, including more than $300M from the Volkswagen Group. They employ over 800 employees globally.
- ANSWEAR.com —
We are an early stage VC for climate tech startups.
Show more...Investment focus
- Industry: Energy, Software, Renewable Energy
- Stage:Seed, Pre-Seed
- Geography: Germany, Switzerland, Finland
Investor stats
- Total investments: 31
- Round size: Seed $536k–$4.3M; Pre-Seed $328k–$1.3M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- CleanHub — Become plastic neutral with CleanHub and prevent ocean bound plastic before it can cause damage
- Openvolt — A developer friendly API for unlocking access to smart meter data across Europe. Build more impactful apps in Energy Efficiency, ESG, EV Charging, Demand Response and a host of other use cases.
- E-mobilio — E-mobilio is a consulting and mediation platform for electromobility.
ICL Startup Accelerator focuses on foodtech and crop nutrition startups, innovative products, and accelerates their market penetration
Show more...Investment focus
- Industry: Biotechnology, Agriculture, Organic Food
- Stage:Seed
- Geography: Israel, Austria
Investor stats
- Total investments: 2
- Round size: Seed $4.3M–$10M
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Lavie bio — Improve food quality, agricultural sustainability and productivity through the introduction of microbiome based ag-biological products.
- Arkeon Biotechnologies — Arkeon turns CO2 into functional, carbon-negative ingredients for food
Impacting the future of medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 118
- Round size: Series A $4.5M–$30M; Series B $12M–$115M; Series C $5.6M–$65M
- Lead/follow: 46% lead, 54% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Mariana Oncology — Mariana Oncology is a biotechnology research industry.
- Seamless Therapeutics — Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner. Seamless technology platform unlocks the reprogramming of recombinases, a highly versatile class of enzymes.
- Complement Therapeutics — Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Turning powerful new Complement System insights into innovative treatments Developing the next generation of complement medicines [chevron-down] Geographic atrophy (late dry age-related macular degeneration) is a chronic eye condition that affects millions - and for which there is
Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 232
- Round size: Series A $4.4M–$53M; Series B $7M–$57M; Series C $10M–$54M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
- Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
- Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
HBM Partners focuses on venture, growth and buy-out financings of private companies as well as investments in public companies.The HBM funds invest in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. Their team supports the growth of the portfolio companies through allstages of development, focusing on adding value by leveraging its experience and HBM's world-wide network in the industry. Investments usually range between $5 million to $50 million.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series B, Series C
- Geography: United States, Germany, Switzerland
Investor stats
- Total investments: 40
- Round size: Series B $7.5M–$125M; Series C $2.5M–$43M
- Lead/follow: 18% lead, 82% follow
- Last fund: May invest from a new fund soon — last raise in 2012
Portfolio highlights
- Dren Bio — Dren Bio is a biotechnology company with a portfolio of attractive projects focused on powerful protein engineering technologies for the depletion of cells, protein aggregates, and other disease-causing agents. It is a holding company business model aimed at creating value with multiple projects as stand-alone assets.
- Neuron23 — Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
- Mineralys Therapeutics — Mineralys Therapeutics, Inc., a private, clinical-stage biopharmaceutical company founded by Catalys Pacific committed to developing best-in-class, novel therapy for the treatment of hypertension. The Company is driven to bring a targeted approach to the management of hypertension via the development of MLS-101. MLS-101, licensed from MitsubishiTanabe Pharma Corporation, is a highly selective and potent aldosterone synthase inhibitor that is being investigated for the treatment of hypertension.
The Austrian Research Promotion Agency (FFG) is the national funding agency for industrial research and development in Austria. As a "one-stop shop" offering a diversified and targeted programme portfolio, the FFG gives Austrian businesses and research facilities quick and uncomplicated access to research funding.The FFG was foundedon 1 September 2004 (pursuant to the FFG Act on establishing a research promotion agency, Federal Law Gazette I No. 73/2004). The FFG is wholly owned by the Republic of Austria, represented by the Federal Ministry for Transport, Innovation and Technology (bmvit) and the Federal Ministry of Science, Research and Economy (BMWFW). As a provider of funding services, however, the FFG also works for other national and international institutions.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Grant, Seed, Angel
- Geography: Austria, United States, Belgium
Investor stats
- Total investments: 37
- Round size: Seed $300k–$1.6M; Grant $66k–$3.5M
- Lead/follow: 19% lead, 81% follow
Portfolio highlights
- Seasy.com — Making Sea Life Easy
- triply — Sustainable mobility made easy. We help companies and organizations design safe and sustainable mobility solutions.
- simplify.art — simplify.art is building a safe admin and communication platform for artists and collectors. It is the first tool with a fully unlimited free basic version. The first service with data sharing between users. And the first to integrate an ecosystem of others working tools (insurance coming summer 2023). In fall 2023 simplify.art will launch a thefirst AI-curated market place that can suggest artworks based on their context and meaning.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Kale United offers a portfolio of over 75+ plant-based game changers
Show more...Investment focus
- Industry: Food and Beverage, Food Processing, Biotechnology
- Stage:Seed, Pre-Seed
- Geography: United Kingdom, Sweden, India
Investor stats
- Total investments: 20
- Round size: Seed $330k–$1.4M; Pre-Seed $100k–$945k
- Lead/follow: 5% lead, 95% follow
Portfolio highlights
- Loki Foods — We're producing sustainable, plant-based foods from the Arctic. Iceland’s first plant-based cod and seafood!
- THE PACK — Nutritionally complete vegan dog food. Grain-free & developed with food scientists & animal nutritionists, try our delicious vegan dog food now.
- Swedish Temptations — Swedish Temptations, founded in 2019 by CEO Pia Qvarnström, built a brand named Bärta for producing organic, vegan and fermented food. The ingredients include Swedish split peas.
Join FoodTech focused investors looking to back impact-driven founders shaping our food system
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, Food Processing
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Israel, United Kingdom
Investor stats
- Total investments: 24
- Round size: Seed $1.9M–$12M; Pre-Seed $500k–$2.1M
- Lead/follow: 4% lead, 96% follow
Portfolio highlights
- PoLoPo — PoLoPo is a biotech company that produces proteins on a large scale and according to specifications. PoLoPo develops a "superAA" plant by employing directed metabolic engineering techniques and fully utilizing plants' capacity as various metabolite and green protein factories. A significant amount of free amino acids can be producedby the superAA. The increased production of amino acids is then translated into an increase in the scale at which proteins are produced in plant organs.
- twig bio — twig bio operates as a bioengineering startup. twig bio using AI and robotics to find sustainable replacements for harmful ingredients.
- WNWN Food Labs — We're WNWN Food Labs and we love food. We're creating delicious, sustainable and ethical alternatives to unsustainable and ethically dubious foods. We're starting with cacao-free chocolate. Changing chocolate? It's Win-Win #alt-chocolate #altchocolate #alt-universe #altuniverse #alt-protein
Tet Ventures is one of the most active global food-tech investors. We work with and invest in technology that can improve the food system.
Show more...Investment focus
- Industry: Food and Beverage, Biotechnology, E-Commerce
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Germany, United Kingdom
Investor stats
- Total investments: 32
- Round size: Seed $150k–$6M; Pre-Seed $1.5M–$2.7M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Farmless — A farmless fermentation platform has the potential to create an entirely new food repertoire, producing proteins, carbohydrates, beneficial fats, vitamins, and minerals from the ground up," explained Oner. "We are creating a new interface between food and electricity by domesticating microbes chosen for their food properties and abilityto grow on renewable energy-based feedstocks.
- Black Sheep Foods — Black Sheep Foods seeks to be the world leader in plant-based lamb and other wild and heritage meats.
- Arkeon Biotechnologies — Arkeon turns CO2 into functional, carbon-negative ingredients for food
Satgana is a Climate Tech VC firm on a mission to invest in planet-positive startups building the Future of Earth.
Show more...Investment focus
- Industry: Energy, Software, CleanTech
- Stage:Pre-Seed
- Geography: Germany, United States, The Netherlands
Investor stats
- Total investments: 10
- Round size: Pre-Seed $600k–$1.4M
- Lead/follow: 40% lead, 60% follow
- Last fund: Likely still investing — raised $32M in 2022
Portfolio highlights
- Loewi — Loewi allows you to sell your two-wheeled companion.
- Revivo — Revivo is an online marketplace for electronics spare parts, tools & accessories.
- Arda Biomaterials — Arda Biomaterials transforms waste feedstocks into smarter, circular biomaterials for fashion, home goods, automotive and more.
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Grant, Series C
- Geography: United States, United Kingdom, Germany
Investor stats
- Total investments: 109
- Round size: Grant $1.2M–$6.8M; Series C $10M–$90M
- Lead/follow: 36% lead, 64% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Vaxxas — Vaxxas develops and commercializes needle-free vaccine delivery system. Vaxxas was incorporated in 2011 and is based in Brisbane, Australia.
- DataDotOrg — data.org brings together philanthropy, technology, academia, and social impact organizations to build the field of data science for social impact.
- Feinstein Institute for Medical Research — Feinstein Institute For Medical Research is the research arm of Northwell Health, the largest health care provider and private employer in New York State. Home to 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes ofbehavioral science, bioelectronic medicine, cancer, health innovations and outcomes, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine.
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 419
- Round size: Series A $10M–$102M; Series B $23M–$120M; Series C $12M–$108M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Evozyne — We have a new way of thinking about proteins. We've uncovered Nature's hidden rules to build Natural Machines. With our partners, we are changing the world.
- Adela — Adela is focused on the detection of cancer and other high-morbidity, high-mortality conditions through a blood test.
- Iambic Therapeutics — Iambic has created a cutting-edge AI-driven platform to tackle the most challenging design problems in drug discovery and address unmet patient need.
IPO Beteiligungs-Management is a private equity company specialized in early stage venture investments.
Show more...Investment focus
- Industry: Sensor, Medical, Wireless
- Stage:Series B
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- SensorDynamics — SensorDynamics was a European semiconductor and MEMS company specialized in developing and manufacturing high-volume micro- and wireless semiconductor sensor products for applications in automotive, industry and high-end consumer sectors. The company was acquired by Maxim Integrated in 2011 for $164 million. SensorDynamics developed and producedcustom-made designs and standard components for use in vehicle stabilization, occupant protection, navigation systems, keyless go systems and autonomous energy generators for wireless and battery free controllers for industrial, automotive and high-end consumer application.[5] With its headquarters in Graz, Austria, SensorDynamics had offices in Italy and Germany and a worldwide sales and distribution network. The company employed about 130 people in 2011.
- EUCODIS Bioscience — EUCODIS Bioscience is an experienced enzyme engineering company, providing industrial customers with high-performing enzymes. Their customers are leaders in the chemical, the pharmaceutical, the food and feed and cosmetics industries.
IBG Beteiligungsgesellschaft Sachsen-Anhalt is a venture capital firm makes investments in territories such as Germany and Denmark.
Show more...Investment focus
- Industry: Electronics, Software, Medical Device
- Stage:Seed, Series A
- Geography: Germany, Austria
Investor stats
- Total investments: 10
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Wingfield — Wingfield ist dein Zugang zu einem virtuellen Tenniserlebnis.
- Baby Sweets — Baby Sweets provides Online shop for beautiful and unusual baby clothes and accessories.Sales of own brands made in EU as well as international brands.
- COMAN Software — COMAN Software provides innovative software for project management in machine and plant construction.
venture capital
Show more...Investment focus
- Industry: Software, Biotechnology, Information Technology
- Stage:Seed, Series A, Series B
- Geography: Hungary, South Korea, United States
Investor stats
- Total investments: 25
- Lead/follow: no public data
Portfolio highlights
- Iskra — Iskra offers web3 gaming opportunities using blockchain and rewards its stakeholders based on their participation.
- On Vacation — On Vacation is a chat-based concierge service where customers may get help making reservations and getting personalized and optimal tours from travel specialists.
- NextChapter — NextChapter is a digital commerce platform that acquires and operates Coupang and Naver-based online native brands in Korea. NextChapter is backed by BlueRun Ventures/BRV Capital Management, Goodwater Capital, Klim Ventures, Fast Ventures and Sandbox Network.NextChapter was founded in 2021 by Joshua Kwon and Jay Chung and is headquarteredin Seoul, Korea.
FCPG Affi
Show more...Investment focus
- Industry: Medical, Biotechnology, Pharmaceutical
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- AFFiRiS — AFFiRiS AG, a Vienna, Austria-based developer of tailor-made peptide vaccines for Alzheimer's disease, Atherosclerosis, Parkinson's disease, hypertension and several other conditions.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Singapore, Ireland
Investor stats
- Total investments: 382
- Round size: Series A $3.5M–$60M; Series B $5.3M–$117M; Series C $11M–$61M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Candesant Biomedical — Candesant Biomedical develops treatment for excessive sweating and hyperhidrosis. It offers a technology that is based on the principle that alkali metals in contact with water generate energy. The insight was that when the amounts of metal and water are controlled, the result is targeted delivery of energy exactly at the site of the water. Itsdevice is designed to target and inactivate the most active sweat glands.The company was founded in 2016 and is headquartered in San Francisco, California.
- Larkspur Biosciences — Larkspur's strategy focuses on the particular ways in which tumours hijack the immune system by developing precision immunotherapies for molecularly defined patient groups to overcome the bottlenecks that allow the tumour to subvert the immune system.
- Crossbow Therapeutics — Crossbow Therapeutics is a seed-stage, stealth-mode oncology startup company. The company develops antibody engineering for intracellular cancer targets.
HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide. Beyond its fund, HCVC supports hardtech founders through Hardware Club, a selective global community of 500+ startups with dedicated resources, partnerships and events.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Manufacturing
- Stage:Seed, Series A, Pre-Seed
- Geography: United States, France, United Kingdom
Investor stats
- Total investments: 68
- Round size: Seed $250k–$3.8M; Series A $2.5M–$31M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely still investing — fund raised in 2023
Portfolio highlights
- Antaris — The Antaris Open Space platform simplifies the design, simulation, manufacturing and operation of satellites.
- Orakl Oncology — Cultivated with love by the Orakl team.
- Renaissance Fusion — Renaissance Fusion is a high-temperature superconductor and stellarator company.
The Austrian Federal Economic Chamber functions as the federal parent organization for the nine State Chambers and 110 trade associations for different industries within Austria's system of economy.
Show more...Investment focus
- Industry: Software, Music, mHealth
- Stage:Seed, Pre-Seed
- Geography: Austria
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Music Traveler — Music Traveler is a rapidly growing aggregator and marketplace, bringing a highly fragmented B2B and B2BC environment to the sharing economy. Music Traveler centralises practice/rehearsal/performing spaces, equipment, and instruction for the performing arts – its mission is to promote the creation, appreciation and interest in music byy reducing barriers, facilitating new interactions.
- The Apollinaire Group (TAG) — Intelligent supply chain management company.
- SCARLETRED — SCARLETRED is an international Digital Health Scaleup revolutionising the global skin care market by the AI powered SCARLETRED®VISION platform system. The problem we solved is subjective skin assessment and lacking standardization in Dermatology. Our medical device certified platform is fully mobile, runs via mobile App on smartphones and connectsto our web platform, which enables to generate smart imaging data and novel AI decision support applications in Dermatology and Telemedicine. The multi award winning technology is supplied international via SaaS to Biopharma and Cosmetics Industry, Hospitals and Medical Experts. Protected via worldwide patents it facilitates standardized skin documentation and remote tracking of skin changes and therapeutic effects via mobile App. Images can be uploaded in a cloud based platform and objectively analysed for visual skin changes over time, such as for allergic reactions, pigmentation changes, acne, psoriasis, disease or wound healing. SCARLETRED provides services on a broad range of dermatologic conditions ranging from B2B to B2B2C applications.
Axilium Holding
Show more...Investment focus
- Industry: Life Science, Biotechnology, Semiconductor
- Stage:Seed
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Sarcura — Sarcura develops a machine platform for the large scale, GMP manufacturing of personalized cell therapies. Our target is to scale global manufacturing capacity for these life saving, patient specific cancer treatments, cost effective and safe for a all patients. We will transform existing manufacturing paradigms by using semiconductor technologyto bring bioprocess control to cellular level.
4SC discovers and develops targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases in indications with high unmet medical needs. These drugs are intended to provide innovative treatment options that are more tolerable and efficacious, and provide a better quality of life.
Show more...Investment focus
- Industry: Health Care, Biotechnology
- Stage:Seed
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Panoptes Pharma — Panoptes is a privately held biotech company focused on developing small molecule based therapies for the treatment of severe eye diseases with high unmet medical need. Panoptes is located in the city center of Vienna, Austria.The development of Panoptes´ clinical candidate PP-001 focuses on a new treatment for autoimmune uveitis, a disease whichis one of the major causes of blindness. As a second indication, adenoviral conjunctivitis will be pursued, a disease for which to date, no treatment is available. Due to its unique mode of action, PP-001 has therapeutic potential for additional inflammatory and viral indications.Panoptes has an experienced team of development experts with a proven track record of developing and commercializing innovative products. The team is developing a focused portfolio of high-performance small molecule products, with its lead clinical candidate PP-001 in preclinical development.
Life Science & DeepTech Fund
Show more...Investment focus
- Industry: Drones, Medical, Software
- Stage:Seed
- Geography: Germany, United States
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- Aerones — Robotic wind turbine service company offering maintenance, inspection and repairs worldwide. Reduce downtime and improve the efficiency of your wind park
- Virtonomy GmbH — Virtonomy is shortening time-to-market of medical products by conducting data driven studies on virtual patients.
- Celeris Therapeutics — Celeris Therapeutics is a deep learning company that uses innovative, computer-based methods to degrade undruggable targets. The platform Celeris One exploits the potential of degrader technologies with accurate predictions of biomolecular interactions and the expansion of chemical space.Celeris One uses methods such as Graph RepresentationLearning, Active Learning, Data Augmentation, and Generative Models to expand the chemical space and leverage sparse and heterogeneous data. This leads to the design of Heterobifunctional and Glue Degraders, as well as Small Molecules.
Lansdowne Investment Company Cyprus
Show more...Investment focus
- Industry: Life Science, Biotechnology, Semiconductor
- Stage:Seed
- Geography: Austria
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Sarcura — Sarcura develops a machine platform for the large scale, GMP manufacturing of personalized cell therapies. Our target is to scale global manufacturing capacity for these life saving, patient specific cancer treatments, cost effective and safe for a all patients. We will transform existing manufacturing paradigms by using semiconductor technologyto bring bioprocess control to cellular level.
RKP InnoInvest provides Investment capital and strategic services support progressive and dynamic start-ups and companies.
Show more...Investment focus
- Industry: Food and Beverage
- Stage:Seed
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Hakuma — Belebender Boost aus der Natur | Premium Zutaten | Bio Matcha-Tee | 100% vegan
- Econutri — Recycling CO2 for sustainable protein production
GCP Gamma Capital Partners is a private Venture Capital investment and Equity consulting firm established in 2002 (GCP Presentation 2020). We focus on dynamic technology and growth companies in Austria, Germany, Switzerland and CEE countries bordering Austria. We aim for value creation and value realization to generate superior returns for our investors and clients.
Show more...Investment focus
- Industry: Mobile, iOS, Mobile Apps
- Stage:Series A, Seed, Series C
- Geography: Austria, Switzerland, United States
Investor stats
- Total investments: 8
- Round size: Seed $546k–$621k
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Wikitude — Wikitude Augmented Reality empowers your iOS, Android & Smart Glasses apps with Image & Object Tracking, Instant tracking (SLAM), Geo AR, and more.
- 42matters AG — 42matters offers a full suite of mobile and connected TV app intelligence solutions, including APIs, file dumps, and visual, web-based platforms.
- Organica Water — Organica Water is a global provider of innovative solutions for the treatment and recycling of wastewater. Over the past two decades Organica has developed a truly unique approach, enabling customers all over the world to build and operate space and energy efficient biological wastewater treatment plants (WWTPs) that blend harmoniously into urbanand residential population centers, ultimately lowering infrastructure costs and facilitating reuse and recycling of treated wastewater. Established in 1998, Organica began as a traditional wastewater design-build company focused exclusively on the Hungarian market. During the first nine years of its life the company built over 75 municipal, commercial, and industrial WWTPs using a variety of different technologies, while continually investing into R&D to futher develop its own IFAS-type solution for biological wastewater treatment. In 2007 Organica sold it's design-build business to focus exclusively on the commercialization of its own biological wastewater treatment solution on a global basis. Today, Organica is an international company operating on three different continents, and the world leader in Fixed-Bed Biofilm Activated Sludge (FBAS) technology,with more than 25 operating references all over the world, and nearly a dozen additional Organica-powered WWTPs currently under construction.
GLS Ventures
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series B
- Geography: Austria
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- Nabriva Therapeutics — Nabriva Therapeutics is a commercial-stage biopharmaceutical company engaged in the development of innovative anti-infective agents to treat serious infections.
Biotechnology Investor funding in Austria at a glance
Stats across 78 deals from 101 investors.
Access all 101 investors in Austria Biotechnology startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Biotechnology Investors in Austria investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 101 investors investing in Austria Biotechnology startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!